2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid CancerKeith C. Bible, Carol K. Wong-Clark, Electron Kebebew et al.|Thyroid|2021Cited by 699
Chaetocin: a promising new antimyeloma agent with in vitro and in vivo activity mediated via imposition of oxidative stressCrescent R. Isham, Keith C. Bible|Blood|2006Cited by 199
Tipifarnib in Head and Neck Squamous Cell Carcinoma With<i>HRAS</i>MutationsAlan L. Ho, Antonio Gualberto, Irene Braña et al.|Journal of Clinical Oncology|2021Cited by 196
Expression of PD-1 and PD-L1 in Anaplastic Thyroid Cancer Patients Treated With Multimodal Therapy: Results From a Retrospective StudyAshish V. Chintakuntlawar, Keith C. Bible|The Journal of Clinical Endocrinology & Metabolism|2017Cited by 134
American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining advanced thyroid cancer and its targeted treatmentDavid C. Shonka, Gregory W. Randolph, Louise Davies et al.|Head & Neck|2022Cited by 110